RecallRadar

FDA Drug recall D-0858-2022

buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle, Rx only Distributed by: Sun Pharmaceutical Industries,…

On 2022-05-18 the FDA classified a Class III recall of buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle, Rx only Distributed by: Sun Pharmaceutical Industries,… by Sun Pharmaceutical Industries, citing presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant….

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0858-2022
ClassificationClass III
Statusterminated
Initiated2022-04-29
Published2022-05-18
Last updated2026-09-13 11:52 UTC
CompanySun Pharmaceutical Industries
DistributionUS

Product

buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle, Rx only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-738-86

Reason

Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.

Identifiers

ndc47335-736-86
ndc47335-736-88
ndc47335-736-08
ndc47335-736-13
ndc47335-737-86
ndc47335-737-88
ndc47335-737-08
ndc47335-737-13
ndc47335-738-86
ndc47335-738-88
ndc47335-738-08
ndc47335-738-13
code_infoLot #: HAC2237A, exp. date 05/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0858-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.